SCRS Welcomes Monroe Biomedical Research as New Global Impact Partner
July 22, 2025 – The Society for Clinical Research Sites (SCRS) is proud to announce Monroe Biomedical Research (MBR) as a new Global Impact Partner (GIP).
Located in Monroe, North Carolina, MBR conducts a broad range of outpatient and inpatient clinical trials, with a focus on infectious disease, internal medicine, cardiometabolic conditions, and respiratory diseases. MBR has distinguished itself as a research leader through consistent high enrollment performance and its ongoing efforts to advance representation in clinical trials, with an ethnically diverse, pre-screened patient database. As a GIP, MBR will work alongside SCRS and leading industry organizations to shape clinical research best practices and champion the voice of the clinical research site globally.
“Becoming an SCRS Global Impact Partner is a meaningful milestone for Monroe Biomedical Research. As a company built on the belief that clinical trials should reflect and serve real-world communities, we’re excited to collaborate with SCRS and fellow leaders to strengthen the voice of sites, improve trial quality, accelerate enrollment, and ultimately improve outcomes for patients everywhere,” said Suvi Gross, CEO, Monroe Biomedical Research.
Marcus Maleck, VP of Global Business Partnerships with SCRS, commented, “Monroe Biomedical Research’s status as one of the highest enrolling research centers in the U.S. brings tremendous value to the SCRS community. Their deep expertise and commitment to advancing inclusive clinical research will strengthen the collaborative efforts of our GIP program. We are proud to welcome MBR and look forward to the meaningful contributions they will make alongside our industry partners.”
The SCRS GIP program fosters a unique collaboration between industry leaders and research sites, facilitating open dialogue and joint efforts to develop solutions to shared challenges across the clinical research landscape. For more information about the SCRS Global Impact Partner program, visit scrsprograms.com.
About Monroe Biomedical Research (MBR)
Monroe Biomedical Research is a world-class clinical research center based in Monroe, North Carolina. MBR conducts Phase I–IV clinical trials and is nationally recognized for its high enrollment rates and commitment to diverse patient participation. Since 2014, MBR has built a robust infrastructure supporting trials in asthma, COPD, diabetes, heart failure, internal medicine, and infectious diseases including COVID-19.
About the Society for Clinical Research Sites (SCRS)
The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 50+ countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs.org. Our voice. Our community. Your success.
